About Celloid
Celloid is a company founded in 2021.. Celloid has raised $1.8 million across 2 funding rounds from investors including FuturePlay and POSTECH Holdings. Celloid offers products and services including 3D Cell Culture Solution and Automated Culture System. Celloid operates in a competitive market with competitors including Pluri, Mo:re, AIM Biotech, The Well Bioscience and S-BIO, among others.
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.8 M (USD)
in 2 rounds
-
Latest Funding Round
$1.8 M (USD), Seed
Jan 31, 2024
-
Investors
FuturePlay
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Celloid
Celloid offers a comprehensive portfolio of products and services, including 3D Cell Culture Solution and Automated Culture System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers 3D systems for reproducible cell cultures in therapy manufacturing.
Facilitates automated processes for organoid development in research.
Funding Insights of Celloid
Celloid has successfully raised a total of $1.8M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.8 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.8M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Seed - Celloid | Valuation |
investors |
|
| Jun, 2022 | Amount | Seed - Celloid | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Celloid
Celloid has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include FuturePlay and POSTECH Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
FuturePlay is engaged in startup investment and acceleration.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Celloid
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Celloid
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Celloid Comparisons
Competitors of Celloid
Celloid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pluri, Mo:re, AIM Biotech, The Well Bioscience and S-BIO, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Next-generation cell-based products are developed across multiple industries.
|
|
| domain | founded_year | HQ Location |
3D cell culture robots are developed for medical research applications.
|
|
| domain | founded_year | HQ Location |
Microfluidic 3D cell culture systems are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Develops xeno-free hydrogels for 3D cell culture and personalized medicine applications.
|
|
| domain | founded_year | HQ Location |
Glycan analysis services and kits are offered by S-BIO.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Celloid
When was Celloid founded?
Celloid was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Is Celloid a funded company?
Celloid is a funded company, having raised a total of $1.8M across 2 funding rounds to date.
What does Celloid do?
Celloid was founded in 2021 in South Korea. Operations are centered in the biotechnology sector, where 3D cell culture solutions for drug development are supplied. The OrgaNest platform is utilized as the main offering, incorporating highly permeable microwells for high-throughput automated culture. A closed continuous perfusion system is integrated to maintain nutrient flow and waste removal in controlled environments. Services support research and testing processes in pharmaceutical applications.
Who are the top competitors of Celloid?
Celloid's top competitors include Pluri, Mo:re and ExCel Matrix Biological Devices.
What products or services does Celloid offer?
Celloid offers 3D Cell Culture Solution and Automated Culture System.
Who are Celloid's investors?
Celloid has 2 investors. Key investors include FuturePlay, and POSTECH Holdings.